Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

New Mpro inhibitors revealed in Vir Biotechnology patent | BioWorld

Vir Biotechnology (NASDAQ:VIR) Sets New 1-Year Low - Here's Why

Vir Biotechnology, Inc. (VIR): Among Stocks Under $10 that Will Triple

ADAR1 Capital Management LLC Sells 255,118 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)

Hepatitis B Virus (HBV) Infection Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies | ABNewswire

Vir Biotechnology, Inc. (NASDAQ:VIR) CEO Sells $474,286.40 in Stock

Prudential Financial Inc. Sells 180,800 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)
Vir Biotechnology Insiders Sell US$1.3m Of Stock, Possibly Signalling Caution

Authority Investment Dhabi Abu - Insider Monkey

Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Consensus Rating of "Moderate Buy" from Analysts

Artisan Partners Limited Partnership Makes New Investment in Vir Biotechnology, Inc. (NASDAQ:VIR)

WINTON GROUP Ltd Reduces Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology (NASDAQ:VIR) Reaches New 1-Year Low - Here's Why
Vir Biotechnology, Inc. (NASDAQ:VIR) is favoured by institutional owners who hold 53% of the company

Fox Run Management L.L.C. Takes $364,000 Position in Vir Biotechnology, Inc. (NASDAQ:VIR)

49,651 Shares in Vir Biotechnology, Inc. (NASDAQ:VIR) Acquired by Fox Run Management L.L.C.

Vir Biotechnology, Inc. (NASDAQ:VIR) Holdings Raised by Charles Schwab Investment Management Inc.
Latest news

Morning Note: Fed Cautious on Tariffs; US-Japan Currency Tensions; Oil Up

Morning Note: UK Inflation Data, US Retail Sales Loom, BoC Rate Expected to Hold